Delivery Order 75F40119D10024-75F40122F19003

This is a firm-fixed-price delivery order awarded by the Food and Drug Administration (FDA), a civilian government agency, to Pharmaron (Exton) Lab Services LLC, doing business as Absorption Systems. The contract, valued at $472,618.73, is for permeability assessments of Biopharmaceutics Classification System (BCS) class 3 drug substances in the presence of antioxidants. The work is to be performed in Silver Spring, Maryland, and the contract has a completion date of May 3, 2023. Pharmaron (Exton) Lab Services LLC is a global contract research organization that has previously conducted work for the FDA and the National Institutes of Health related to COVID-19 treatments, pharmacokinetic studies, and Biopharmaceutics Classification System waivers for generic drugs. This contract does not have a set-aside designation.